CHEK2 and complete blood cell count: Interestingly, most CBC studies evaluating CHEK2 have focused on the c.1100delC variant (15,25,26), the results of which have been inconsistent; 1 study observed associations with CBC incidence and long-term survival (26), whereas the WECARE consortium reported no association but acknowledged small sample size and limited power (25).